EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Subretinal Fluid Correlates with Increased Macular Volume in Diabetic Macular Edema

Hugo Le Boité, Salomé Maunoury, Aude Couturier

Ophthalmologica · 2026-10-08 · 1-1

DOI: 10.1159/oph/aeeag014 ↗
AbstractBibliografische Angaben

Abstract

Introduction: This study aimed to determine the prevalence and clinical phenotype of subretinal fluid (SRF) in eyes with diabetic macular edema (DME). Methods: A retrospective study was conducted in treatment-naive patients with DME. The presence of SRF, hard exudates, and cystoid spaces with hyperreflective material on optical coherence tomography B-scans, along with central macular thickness (CMT) in the 1-mm, 3-mm, and 6-mm central areas, was assessed, and the correlation between the presence of SRF and macular thickness was estimated using linear mixed-effects models. Results: Of 101 eyes from 63 patients (49% men, mean age 61.31 ± 9.45 years), 36% had SRF. SRF was significantly and independently associated with macular thickness, with higher 1-mm, 3-mm and 6-mm CMT compared to eyes without SRF (β = 104.7 [95% CI, 53.5; 156] µm, p < 0.001; β = 80.5 [95% CI, 45.9; 115.2] µm, p < 0.001; β = 55.1 [95% CI, 30.1; 80] µm, p < 0.001, respectively). Even though macular thickness was significantly associated with visual acuity, SRF was not associated (β = 0.127 [95% CI, −0.034; 0.287]; p = 0.12). However, in eyes with SRF, width (but not height) of the SRF was independently associated with lower visual acuity (β = 0.00017; [95% CI: 0.00003–0.00031]; p = 0.028). Conclusion: DME patients with SRF exhibited higher macular thickness compared to those without SRF, suggesting SRF is an anatomical marker of a more severe exudative process. However, SRF’s independent impact on visual acuity was limited and modest in magnitude, suggesting further studies could improve our understanding of the pathophysiological and clinical significance of SRF in DME.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →